Literature DB >> 3531450

Course of nephropathic cystinosis after age 10 years.

W A Gahl, J A Schneider, J G Thoene, R Chesney.   

Abstract

We identified 80 patients with nephropathic cystinosis older than age 10 years in the United States and Canada. The oldest reported individual was 26 years of age. Ninety percent of patients had received at least one renal allograft. Age at the time of first transplant varied between 7 and 17 years (mean 10.0 years). Almost three fourths of the patients required thyroid replacement, 27% had splenomegaly, and 42% had hepatomegaly. Photophobia was noted in 86% of patients, decreased visual acuity in 32%, and corneal ulcerations in 15%. Neurologic involvement, renal osteodystrophy, and diabetes mellitus were unusual. All these late complications of nephropathic cystinosis contribute to a description of the natural history of the disease and provide a rationale for the therapeutic use of cystine-depleting agents after renal transplantation.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3531450     DOI: 10.1016/s0022-3476(86)80221-9

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  19 in total

1.  Cystine accumulation attenuates insulin release from the pancreatic β-cell due to elevated oxidative stress and decreased ATP levels.

Authors:  Bernadette McEvoy; Rodolfo Sumayao; Craig Slattery; Tara McMorrow; Philip Newsholme
Journal:  J Physiol       Date:  2015-11-18       Impact factor: 5.182

Review 2.  Ophthalmic manifestations and histopathology of infantile nephropathic cystinosis: report of a case and review of the literature.

Authors:  Ekaterini Tsilou; Min Zhou; William Gahl; Pamela C Sieving; Chi-Chao Chan
Journal:  Surv Ophthalmol       Date:  2007 Jan-Feb       Impact factor: 6.048

3.  [Bilateral crystalline deposits in corneal stroma].

Authors:  F N Auerbach; R Khoramnia; G U Auffarth; J A Carmona Hernandez; T Tandogan; S Sel
Journal:  Ophthalmologe       Date:  2016-06       Impact factor: 1.059

4.  Cystinosis as a cause of noncirrhotic portal hypertension.

Authors:  Simona Rossi; Steven K Herrine; Victor J Navarro
Journal:  Dig Dis Sci       Date:  2005-07       Impact factor: 3.199

Review 5.  Update on nephropathic cystinosis.

Authors:  J A Schneider; B Katz; R B Melles
Journal:  Pediatr Nephrol       Date:  1990-11       Impact factor: 3.714

6.  A randomized controlled crossover trial with delayed-release cysteamine bitartrate in nephropathic cystinosis: effectiveness on white blood cell cystine levels and comparison of safety.

Authors:  Craig B Langman; Larry A Greenbaum; Minnie Sarwal; Paul Grimm; Patrick Niaudet; Georges Deschênes; Elisabeth Cornelissen; Denis Morin; Pierre Cochat; Debora Matossian; Segolene Gaillard; Mary Jo Bagger; Patrice Rioux
Journal:  Clin J Am Soc Nephrol       Date:  2012-05-03       Impact factor: 8.237

7.  Renal transplantation in 22 children with nephropathic cystinosis.

Authors:  J H Ehrich; J Brodehl; D I Byrd; S Hossfeld; P F Hoyer; K P Leipert; G Offner; G Wolff
Journal:  Pediatr Nephrol       Date:  1991-11       Impact factor: 3.714

8.  Clinical polymorphism of cystinosis encephalopathy. Results of treatment with cysteamine.

Authors:  M Broyer; M J Tête; G Guest; J P Berthélémé; F Labrousse; M Poisson
Journal:  J Inherit Metab Dis       Date:  1996       Impact factor: 4.982

Review 9.  Nephropathic cystinosis: late complications of a multisystemic disease.

Authors:  Galina Nesterova; William Gahl
Journal:  Pediatr Nephrol       Date:  2008-06       Impact factor: 3.714

10.  Late symptoms in infantile cystinosis.

Authors:  M Broyer; M J Tete; M C Gubler
Journal:  Pediatr Nephrol       Date:  1987-07       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.